PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Broderick, Joseph P.
TI  - IMS III: Results and Perspective
DP  - 2013 May 01
TA  - MD Conference Express
PG  - 28--29
VI  - 13
IP  - 1
4099  - http://mdc.sagepub.com/content/13/1/28.short
4100  - http://mdc.sagepub.com/content/13/1/28.full
AB  - Stroke is the second leading cause of death with 16 million strokes occurring worldwide each year. The randomized Interventional Management of Stroke III Trial [IMS III] study was designed to test whether endovascular therapy following IV tPA was more efficacious than IV tissue plasminogen activator (tPA) alone [Broderick JP et al. N Engl J Med 2013].